| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.22 | $1.18 | $1.33 | $1.24 | $1.25 | $0.74 | $0.89 | $0.43 |
| EPS (Diluted) | $1.21 | $1.17 | $1.32 | $1.23 | $1.24 | $0.73 | $0.87 | $0.41 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.4B | $3.3B | $3.2B | $2.9B | $2.6B | $2.2B | $2.2B | $2.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.1B | $0.2B |
| Total Liabilities | $3.0B | $3.0B | $2.9B | $2.6B | $2.3B | $1.9B | $1.8B | $2.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.4B | $0.4B | $0.3B | $0.4B | $0.3B | $0.3B | $0.3B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | — |
| Investing Cash Flow | $-0.1B | $-0.1B | $-0.5B | $0.1B | $-0.3B | $-0.1B | $-0.0B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.1B | $0.0B | $-0.1B | $0.3B | $0.4B | $0.0B | $-0.1B | — |